Ticker Report StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a report issued on Thursday. The brokerage set a "sell" rating on the biopharmaceutical company's stock...\n more…
Ticker Report Equities research analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a research note issued on Wednesday. The firm set a "sell" rating on the...\n more…
Ticker Report Analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a research report issued on Tuesday. The firm set a "sell" rating on the biopharmaceutical company's...\n more…
Ticker Report Trevena (NASDAQ:TRVN - Get Free Report) and KALA BIO (NASDAQ:KALA - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based...\n more…